MedPath

Hormone Therapy in Treating Patients With Prostate Cancer

Phase 2
Completed
Conditions
Prostate Cancer
Sexual Dysfunction and Infertility
Interventions
Other: quality-of-life assessment
Registration Number
NCT00003323
Lead Sponsor
Alliance for Clinical Trials in Oncology
Brief Summary

RATIONALE: Male hormones can stimulate the growth of prostate cancer cells. Hormone therapy using flutamide and finasteride may fight prostate cancer by reducing the production of male hormones.

PURPOSE: Phase II trial to study the effectiveness of flutamide and finasteride in treating prostate cancer patients with high PSA levels who were previously treated with radiation therapy or radical prostatectomy.

Detailed Description

OBJECTIVES:

* Determine the efficacy of finasteride and flutamide in suppressing prostate specific antigen (PSA) levels in patients with elevated PSA after definitive radiation therapy or radical prostatectomy for prostate cancer.

* Assess sexual function and other quality of life issues during this therapy.

* Estimate the response to flutamide withdrawal in this group of patients who have not had a major reduction in circulating testosterone levels.

* Measure the response rate to further hormonal manipulation with combined androgen blockade after the failure of this therapy.

* Obtain data that may predict more aggressive disease.

OUTLINE: This is a multicenter study.

Patients receive finasteride and flutamide by mouth three times a day. Patients experiencing recurrence or a greater than 4 nu/mL (above 50%) increase in PSA level will discontinue flutamide treatments. Otherwise, patients continue therapy in the absence of unacceptable toxicity or disease progression.

Quality of life is assessed prior to therapy and at 3 and 6 months.

Patients are followed every 3 months for one year and every 6 months thereafter.

PROJECTED ACCRUAL: This study will accrue 100 patients over 2 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
101
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Hormone Therapyquality-of-life assessmentTreatment of prostate cancer pts post radiation or surgery with potency sparing hormones
Hormone TherapyfinasterideTreatment of prostate cancer pts post radiation or surgery with potency sparing hormones
Hormone TherapyflutamideTreatment of prostate cancer pts post radiation or surgery with potency sparing hormones
Primary Outcome Measures
NameTimeMethod
PSA levels1 year post treatment
Secondary Outcome Measures
NameTimeMethod
QOL issues associated with treatment protocol3 & 6 months

Trial Locations

Locations (43)

Memorial Sloan-Kettering Cancer Center

🇺🇸

New York, New York, United States

Marlene & Stewart Greenebaum Cancer Center, University of Maryland

🇺🇸

Baltimore, Maryland, United States

University of Massachusetts Memorial Medical Center

🇺🇸

Worcester, Massachusetts, United States

Veterans Affairs Medical Center - Chicago (Westside Hospital)

🇺🇸

Chicago, Illinois, United States

Dana-Farber Cancer Institute

🇺🇸

Boston, Massachusetts, United States

CCOP - Christiana Care Health Services

🇺🇸

Wilmington, Delaware, United States

Barnes-Jewish Hospital

🇺🇸

Saint Louis, Missouri, United States

New York Presbyterian Hospital - Cornell Campus

🇺🇸

New York, New York, United States

Mount Sinai Medical Center, NY

🇺🇸

New York, New York, United States

University of Chicago Cancer Research Center

🇺🇸

Chicago, Illinois, United States

Schneider Children's Hospital at North Shore

🇺🇸

Manhasset, New York, United States

Veterans Affairs Medical Center - Buffalo

🇺🇸

Buffalo, New York, United States

Veterans Affairs Medical Center - Togus

🇺🇸

Togus, Maine, United States

Veterans Affairs Medical Center - Columbia (Truman Memorial)

🇺🇸

Columbia, Missouri, United States

State University of New York - Upstate Medical University

🇺🇸

Syracuse, New York, United States

Holden Comprehensive Cancer Center at The University of Iowa

🇺🇸

Iowa City, Iowa, United States

CCOP - Southeast Cancer Control Consortium

🇺🇸

Winston-Salem, North Carolina, United States

Ellis Fischel Cancer Center - Columbia

🇺🇸

Columbia, Missouri, United States

MBCCOP - Massey Cancer Center

🇺🇸

Richmond, Virginia, United States

Veterans Affairs Medical Center - White River Junction

🇺🇸

White River Junction, Vermont, United States

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.

🇺🇸

Syracuse, New York, United States

Veterans Affairs Medical Center - Birmingham

🇺🇸

Birmingham, Alabama, United States

Veterans Affairs Medical Center - San Francisco

🇺🇸

San Francisco, California, United States

UCSF Cancer Center and Cancer Research Institute

🇺🇸

San Francisco, California, United States

University of Nebraska Medical Center

🇺🇸

Omaha, Nebraska, United States

Veterans Affairs Medical Center - Minneapolis

🇺🇸

Minneapolis, Minnesota, United States

CCOP - Southern Nevada Cancer Research Foundation

🇺🇸

Las Vegas, Nevada, United States

Veterans Affairs Medical Center - Durham

🇺🇸

Durham, North Carolina, United States

Duke Comprehensive Cancer Center

🇺🇸

Durham, North Carolina, United States

University of California San Diego Cancer Center

🇺🇸

La Jolla, California, United States

Roswell Park Cancer Institute

🇺🇸

Buffalo, New York, United States

Comprehensive Cancer Center at Wake Forest University

🇺🇸

Winston-Salem, North Carolina, United States

Walter Reed Army Medical Center

🇺🇸

Washington, District of Columbia, United States

University of Tennessee, Memphis Cancer Center

🇺🇸

Memphis, Tennessee, United States

CCOP - Mount Sinai Medical Center

🇺🇸

Miami Beach, Florida, United States

Norris Cotton Cancer Center

🇺🇸

Lebanon, New Hampshire, United States

Washington University Siteman Cancer Center

🇺🇸

Saint Louis, Missouri, United States

Lineberger Comprehensive Cancer Center, UNC

🇺🇸

Chapel Hill, North Carolina, United States

CCOP - North Shore University Hospital

🇺🇸

Manhasset, New York, United States

Veterans Affairs Medical Center - Syracuse

🇺🇸

Syracuse, New York, United States

Veterans Affairs Medical Center - Memphis

🇺🇸

Memphis, Tennessee, United States

Veterans Affairs Medical Center - Richmond

🇺🇸

Richmond, Virginia, United States

Rhode Island Hospital

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath